A new policy brief from Health Affairs and the Robert Wood Johnson Foundation (RWJF) looks at a renewed debate over whether and how the Food and Drug Administration (FDA) should regulate the pharmaceutical industry’s communication to physicians about
Read More...
Read the complete post at http://healthaffairs.org/blog/2016/07/06/new-health-policy-brief-off-label-drug-promotion/
Posted
Jul 06 2016, 09:00 AM
by
Health Affairs BlogHealth Affairs Blog